NWPF

News ArchivesRead News

Tumours found in rats given stem cells during Parkinson’s study

Thursday October 26, 2006

October 23, 2006 (CBC News) - A potential leap in the treatment of Parkinson’s disease has been tempered with a setback as rats injected with embryonic stem cells were essentially cured of Parkinson’s-like symptoms, but soon developed brain tumours.

When researchers at the University of Rochester transplanted human embryonic stem (HES) cells into the rats, "the implants yielded a significant, substantial and long-lasting restitution of motor function," according to a study published Monday in the online journal of Nature Medicine.

But after 10 weeks into the trial, the scientists discovered the tumours had begun to grow in every rat.

The findings are considered a blow to plans to use HES cells to grow tissues for human transplant.

Stem cells can be thought of as blank slates or cells that have yet to become specialized. They have the ability to become any type of cell to form skin, bones, organs or other body parts.

In particular, researchers have seen the potential for HES cell therapy in curing Parkinson’s because the disease requires only a single cell type that produces dopamine. Dopamine is a neurotransmitter that carries signals between neurons (brain cells).

The brain cells containing dopamine become injured or die in a Parkinson’s patient, which often leads to the person being unable to control physical movements, or they suffer from tremors.

Canada and several other countries have approved strict laws that limit research on stem cells from human embryos.

Recent News

Jul 24 - Parkinson's: Mutant gene interaction may pave the way for new treatments
Jul 22 - Boxing training used to fight against Parkinson's disease
Jul 17 - Stem cell treatment breakthrough could cure Parkinson’s patients
Jul 14 - Cancer drug shows early promise for Parkinson's disease
Jul 13 - Opinion: Dividing the Caregiving Responsibilities Between Siblings
Jul 12 - Researchers make advance in possible treatments for Gaucher, Parkinson’s diseases
Jul 11 - Parkinson’s Head Trauma Link Looks Even Stronger
Jul 7 - Penn students’ start-up XEED puts wearables to work against Parkinson’s disease
Jul 5 - Last Patient Enrolled in Pivotal Phase 3 Parkinson’s Disease Trial, Cynapsus Therapeutics Says
Jun 29 - Exoskeleton Could Quell the Tremors of Parkinson's Disease Patients at Crucial Moments
Jun 28 - Parkinson's disease: New protein discovery could fuel new treatments
Jun 27 - Study finds direct evidence linking Parkinson’s to autoimmune disease; 2 genes that are key regulators of immune system discovered
Jun 27 - Blocking key enzyme halts parkinson's disease symptoms in mice
Jun 23 - Parkinson's Research Might Benefit from Novel Discovery of Zinc Transport Protein Structure
Jun 23 - Parkinson's disease breakthrough 'could lead to cure'
Jun 20 - More American men diagnosed with Parkinson's
Jun 15 - First monkey genetically engineered to have Parkinson’s created
Jun 14 - Fighting Parkinson's in the lab
Jun 9 - A New Gene Has Been Linked to Parkinson's Disease
Jun 6 - A neurologist weighs in on Muhammad Ali's battle with Parkinson's disease